24 /100
LOW RISK
Score updated May 29, 2026

UNCY — Unicycive Therapeutics, Inc. Dilution Risk Tracker

Track UNCY dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track UNCY — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for UNCY.
🔔 Track UNCY — Get forecast alerts →

💹 Market Data

Market Cap$187.43M
Shares Outstanding26.70M
Float24.28M
Cash$54.59M
Debt$815.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 30.5% shares (2025Q4 vs prior)
35 institutional holders · 8.20M shares
#1 Vivo Capital, LLC 1.79M shares
#2 MILLENNIUM MANAGEMENT LLC 1.01M shares
#3 Octagon Capital Advisors LP 1.00M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest2.15M
Days to Cover4.6
% of Float8.9%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2021
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track UNCY Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking UNCY — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for UNCY
📊 UNCY FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 UNCY Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.